SPRB Spruce Biosciences Inc
3,021
$0.8327
$0.0057
(0.68%)
| Watchers | 3,021 |
| 52-Wk Low | $0.6711 |
| 52-Wk High | $5.95 |
| Market Cap | $34.26M |
| Volume | 243,215.00 |
| 52-Wk High | $5.95 |
| 52-Wk Low | $0.6711 |
Spruce Biosciences to Participate in May Investor ConferencesBusiness Wire • 9 days ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Share to Feed
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...
NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ( Spruce or the Company ) (NASDAQ: SPRB). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Spruce Biosciences, Inc...
NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ( Spruce or the Company ) (NASDAQ: SPRB). Such investors are...
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spruce Biosciences, Inc. (Spruce or the Company) (NASDAQ: SPRB). Investors who...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...